Exposure draft consultation

CL01-REPSOL- EFRAG DCL- Equity Method 2024
Comment Letter Received
CL02- AcE-EFRAG DCL- Equity Method 2024.pdf
Comment Letter
CL03 - ANC - EFRAG DCL- Equity Method 2024.pdf
Comment Letter
CL04-BE-EFRAG DCL- Equity Method 2024.pdf
Comment Letter Received
CL05-SCRB-EFRAG DCL Equity Method 2024.pdf
Comment Letter
CL06-OIC-EFRAG DCL- Equity Method 2024.pdf
Comment Letter
CL07A-AFRAC-EFRAG DCL - Equity method 2024.pdf
Comment Letter
CL07B-AFRAC-EFRAG DCL - Equity method 2024.pdf
Comment Letter Received
CL08 - NASB - EFRAG DCL- Equity Method 2024.pdf
Comment Letter Received
CL09-DASB- EFRAG DCL - Equity Method.pdf
Comment Letter
CL10-Allianz Group-EFRAG DCL-Equity Method 2024.pdf
Comment Letter
CL11 - ESMA - EFRAG DCL-Equity Method 2024.pdf
Comment Letter Received
CL12-ESBG-EFRAG DCL Equity Method 2024.pdf
Comment Letter
CL13 - EFFAS - EFRAG DCL-Equity Method 2024.pdf
Comment Letter
CL14 - UCM - EFRAG DCL -Equity Method 2024.pdf
Comment Letter
CL15-ICAC-EFRAG DCL Equity Method 2024.pdf
Comment Letter
CL16 - DASC - EFRAG DCL Equity Method 2024.pdf
Comment Letter
CL17 - DRSC - EFRAG DCL Equity Method 2024 (received after EFRAG FCL approval).pdf
Comment Letter Received
CL18 - VOLKSWAGEN - EFRAG DCL Equity Method 2024 (received after EFRAG FCL approval).pdf
Comment Letter Received
Equity Method ED - Draft Comment letter.pdf
Draft comment letter
Equity Method ED - Final Comment letter.pdf
Comment Letter
Feedback statement on Equity Method DCL.pdf
Feedback statement - comments received